It's been a pretty great week for Japan Lifeline Co., Ltd. (TSE:7575) shareholders, with its shares surging 14% to JP¥1,570 in the week since its latest quarterly results. Results overall were respectable, with statutory earnings of JP¥133 per share roughly in line with what the analysts had forecast. Revenues of JP¥16b came in 3.7% ahead of analyst predictions. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. We've gathered the most recent statutory forecasts to see whether the analysts have changed their earnings models, following these results.
Taking into account the latest results, the most recent consensus for Japan Lifeline from three analysts is for revenues of JP¥62.4b in 2027. If met, it would imply a credible 3.2% increase on its revenue over the past 12 months. Statutory earnings per share are forecast to descend 10% to JP¥119 in the same period. Yet prior to the latest earnings, the analysts had been anticipated revenues of JP¥61.8b and earnings per share (EPS) of JP¥125 in 2027. The analysts seem to have become a little more negative on the business after the latest results, given the small dip in their earnings per share numbers for next year.
See our latest analysis for Japan Lifeline
It might be a surprise to learn that the consensus price target was broadly unchanged at JP¥1,553, with the analysts clearly implying that the forecast decline in earnings is not expected to have much of an impact on valuation. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. Currently, the most bullish analyst values Japan Lifeline at JP¥1,710 per share, while the most bearish prices it at JP¥1,400. This is a very narrow spread of estimates, implying either that Japan Lifeline is an easy company to value, or - more likely - the analysts are relying heavily on some key assumptions.
Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. The analysts are definitely expecting Japan Lifeline's growth to accelerate, with the forecast 4.3% annualised growth to the end of 2027 ranking favourably alongside historical growth of 3.1% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 6.4% per year. So it's clear that despite the acceleration in growth, Japan Lifeline is expected to grow meaningfully slower than the industry average.
The Bottom Line
The biggest concern is that the analysts reduced their earnings per share estimates, suggesting business headwinds could lay ahead for Japan Lifeline. On the plus side, there were no major changes to revenue estimates; although forecasts imply they will perform worse than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.
Keeping that in mind, we still think that the longer term trajectory of the business is much more important for investors to consider. At Simply Wall St, we have a full range of analyst estimates for Japan Lifeline going out to 2029, and you can see them free on our platform here..
We also provide an overview of the Japan Lifeline Board and CEO remuneration and length of tenure at the company, and whether insiders have been buying the stock, here.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.